Francis Collins: Scientists must engage with the world
In Compton Lecture, NIH director details the importance of reaching out to others.
Researchers engineer new mouse model to study disease
Time-saving tool takes advantage of CRISPR gene-editing technology.
Inventor creates tiny technologies for medicine; awarded $500,000 Lemelson-MIT Prize
Sangeeta Bhatia combines clinical and engineering perspectives to tackle complex health challenges.
Kellis to lead MIT team in new phase of GTEx project to elucidate basis of disease predisposition
NIH-sponsored work to characterize genetic variation in human tissues with roles in diabetes, heart disease, and cancer.
$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research
Transformative partnership with Ted Stanley will spur researchers to reveal biology of psychiatric disorders.
Keeping it simple (for a bioinformatician)
Alumnus strikes delicate balances in big data — helping define the future of health care.
Fast synthesis could boost drug development
Chemists devise a new way to manufacture peptide drugs, which hold promise for treating many diseases.
New view of tumors’ evolution
Sequencing of cancer cell genomes reveals potential new drug targets for an aggressive type of lung cancer.
Research reveals structure of key CRISPR complex
Work reveals how a genome-editing tool works to correct errors in the genetic code.
Broad Institute launches next decade with new $100 million gift
Historic pledge from Eli and Edythe Broad to propel institute into a new decade of biomedical discovery to benefit patients.
Researchers develop new method for understanding network connections
Technique could be applied to the study of disease, social networks and other diverse fields.
Controlling genes with light
New technique can rapidly turn genes on and off, helping scientists better understand their function.
Research update: Genome editing becomes more accurate
Improved technique makes it easier to add or delete genes in living cells, with less risk of off-target DNA damage.